TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
The Global Alliance for TB Drug Development (TB Alliance) has...
Lhyfe, a producer of green and renewable hydrogen for mobility and industry, has disclosed that the French Prime Minister has officially confirmed, by signature, a €149 million grant...